Announcements Trials
Browse Landscape

Status

Completed 4

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 165Observational 4

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Breast 1

Conditions

Pancreatic Neoplasms 2Neoplasm Metastasis 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Albumin-Bound Paclitaxel × Clear all
NCT02799862 2021-10-06

NEPTUN

iOMEDICO AG

Completed
408 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT02555813 2020-10-19

Treatment of Pancreatic Cancer With Abraxane

Celgene

Completed
317 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02021500 2019-11-01

A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.

Celgene

Completed
40 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02555696 2017-02-23

Abraxane in Treatment of Metastatic Breast Cancer

Celgene

Completed
203 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡